NCT06090136View on ClinicalTrials.gov

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

July 22, 2022

Conditions
Erectile Dysfunction
Interventions
DRUG

TPN171H

5 mg TPN171H tablets，single dose,oral

Trial Locations (1)

200031

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY

NCT06090136 - Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects | Biotech Hunter | Biotech Hunter